Exforge 10/160mg Tablets

Manufacturer NOVARTIS Active Ingredient Amlodipine and Valsartan(am LOE di peen & val SAR tan) Pronunciation am-LOE-di-peen & val-SAR-tan
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
đŸˇī¸
Drug Class
Antihypertensive
đŸ§Ŧ
Pharmacologic Class
Calcium Channel Blocker (Dihydropyridine) / Angiotensin II Receptor Blocker (ARB)
🤰
Pregnancy Category
Not applicable (contraindicated in 2nd/3rd trimesters, see Black Box Warning)
✅
FDA Approved
Jun 2007
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Exforge is a combination medicine containing two drugs, amlodipine and valsartan, used to treat high blood pressure (hypertension). Amlodipine helps relax blood vessels, and valsartan blocks a natural substance in the body that narrows blood vessels. Together, they help lower blood pressure, which can reduce the risk of heart attack and stroke.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication with or without food, and at the same time every day. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

It's also important to stay hydrated by drinking plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of reach of children and pets. When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Instead, check with your pharmacist for guidance on the best disposal method or explore local drug take-back programs.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take medication exactly as prescribed, usually once daily.
  • Do not stop taking the medication without consulting your doctor, even if you feel well.
  • Continue to follow a low-sodium diet as recommended by your doctor or dietitian.
  • Engage in regular physical activity (e.g., walking, jogging) as advised by your doctor.
  • Limit alcohol intake.
  • Avoid smoking.
  • Monitor your blood pressure at home as instructed by your healthcare provider.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: One tablet (10mg amlodipine / 160mg valsartan) orally once daily
Dose Range: 5 - 320 mg

Condition-Specific Dosing:

hypertension: Initial dose typically 5mg amlodipine / 160mg valsartan or 10mg amlodipine / 160mg valsartan once daily. Max dose 10mg amlodipine / 320mg valsartan once daily.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (Safety and efficacy not established in pediatric patients <18 years of age)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment required.
Moderate: No dosage adjustment required.
Severe: Use with caution. Monitor potassium and renal function. Valsartan clearance is reduced in severe renal impairment (CrCl <30 mL/min).
Dialysis: Not dialyzable (valsartan). Amlodipine is not dialyzable. Use with caution; monitor closely.

Hepatic Impairment:

Mild: No dosage adjustment required for amlodipine. For valsartan, consider lower starting dose (e.g., 80mg valsartan component) in patients with mild-to-moderate hepatic impairment without cholestasis.
Moderate: Use with caution. Consider lower starting dose for valsartan component. Amlodipine exposure is increased in hepatic impairment. Monitor closely.
Severe: Not recommended (no experience in severe hepatic impairment or biliary obstruction).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Exforge combines two antihypertensive agents with complementary mechanisms to control blood pressure: Amlodipine, a dihydropyridine calcium channel blocker (CCB), inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to peripheral arterial vasodilation and reduction in peripheral vascular resistance. Valsartan, an angiotensin II receptor blocker (ARB), selectively blocks the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle and the adrenal gland. This blockade inhibits the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to vasodilation, reduced aldosterone secretion, and decreased sodium and water reabsorption.
📊

Pharmacokinetics

Absorption:

Bioavailability: Amlodipine: 64-90%; Valsartan: 23% (absolute)
Tmax: Amlodipine: 6-12 hours; Valsartan: 2-4 hours
FoodEffect: Amlodipine: Not affected by food; Valsartan: Decreased AUC and Cmax by about 40% and 50% respectively, but not clinically significant for blood pressure lowering.

Distribution:

Vd: Amlodipine: 21 L/kg; Valsartan: 17 L
ProteinBinding: Amlodipine: ~97.5%; Valsartan: ~94-97%
CnssPenetration: Amlodipine: Limited; Valsartan: Limited

Elimination:

HalfLife: Amlodipine: 30-50 hours; Valsartan: 6-9 hours
Clearance: Amlodipine: 7 mL/min/kg; Valsartan: 2 L/h (renal), 30 L/h (total plasma)
ExcretionRoute: Amlodipine: ~60% urine (inactive metabolites), 10% urine (unchanged); Valsartan: ~83% feces (unchanged), ~13% urine (unchanged)
Unchanged: Amlodipine: ~10%; Valsartan: ~13% (urine), ~83% (feces)
âąī¸

Pharmacodynamics

OnsetOfAction: Amlodipine: 24-48 hours (full effect); Valsartan: 2 hours
PeakEffect: Amlodipine: 6-12 hours; Valsartan: 2-4 hours
DurationOfAction: Amlodipine: 24 hours; Valsartan: 24 hours

Safety & Warnings

âš ī¸

BLACK BOX WARNING

FETAL TOXICITY: If pregnancy is detected, discontinue Exforge as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high potassium levels, such as:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Signs of liver problems, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Severe dizziness or fainting
New or worsening chest pain
Swelling in the arms or legs
Stiff muscles, shakiness, or abnormal muscle movements

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Dizziness
Nose or throat irritation
* Signs of a common cold

This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting
  • Swelling of the face, lips, tongue, or throat (signs of angioedema)
  • Difficulty breathing or swallowing
  • Yellowing of the skin or eyes (jaundice)
  • Unusual tiredness or weakness
  • Signs of high potassium (e.g., muscle weakness, slow or irregular heartbeat)
  • Significant swelling in the ankles or feet that is new or worsening
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
If you have kidney disease, as this may affect how your body processes the medication.
If you are taking a medication that contains aliskiren, particularly if you have diabetes or kidney problems, as this combination may increase the risk of adverse effects.
If you are breast-feeding, as you should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
âš ī¸

Precautions & Cautions

Important Information to Share with Your Healthcare Team

Inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Precautions to Ensure Your Safety

Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position. Be cautious when climbing stairs.

Monitoring Your Health

Check your blood pressure as directed by your healthcare provider. Additionally, have your blood work and other laboratory tests performed as scheduled by your doctor.

Potential Cardiovascular Risks

Although rare, new or worsening chest pain can occur after starting this medication or increasing the dose. In some cases, a heart attack may happen. This risk may be higher in individuals with severe heart blood vessel disease. Discuss these potential risks with your doctor.

Interactions with Other Medications and Products

Before using over-the-counter (OTC) products that may increase blood pressure, consult with your doctor. These products include cough and cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen, and certain natural products or aids.

If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, inform your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor.

Additional Considerations

It may take several weeks to experience the full effects of this medication. Before consuming alcohol, consult with your doctor.

In hot weather or during physical activity, be cautious and drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.

Special Considerations for Older Adults

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (very low blood pressure)
  • Bradycardia (slow heart rate)
  • Tachycardia (fast heart rate)
  • Dizziness
  • Lightheadedness
  • Shock
  • Peripheral vasodilation with reflex tachycardia
  • Electrolyte disturbances (e.g., hyperkalemia)

What to Do:

Call 911 or your local emergency number immediately. For advice, call a poison control center at 1-800-222-1222. Management is supportive, including elevation of extremities, fluid resuscitation, and vasopressors if needed for hypotension. Calcium gluconate may be administered intravenously for amlodipine overdose. Hemodialysis is not effective for removing amlodipine or valsartan.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment)
  • Sacubitril/valsartan (Entresto) - due to increased risk of angioedema
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • Potassium supplements
  • Salt substitutes containing potassium
  • NSAIDs (including COX-2 inhibitors)
  • Lithium
  • CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir, clarithromycin)
  • CYP3A4 inducers (e.g., rifampin, St. John's Wort)
🟡

Moderate Interactions

  • Other antihypertensives (additive effect)
  • Grapefruit juice (for amlodipine)
  • Simvastatin (amlodipine increases simvastatin exposure)
  • Dantrolene (IV) (for amlodipine, risk of hyperkalemia and cardiovascular depression)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide therapy initiation.

Timing: Prior to initiation

Serum Creatinine and eGFR

Rationale: To assess renal function, especially important for valsartan and in patients at risk for renal impairment.

Timing: Prior to initiation

Serum Potassium

Rationale: To assess baseline potassium levels, as valsartan can cause hyperkalemia.

Timing: Prior to initiation

Liver Function Tests (LFTs)

Rationale: To assess hepatic function, as both drugs are metabolized or eliminated by the liver, and hepatic impairment can affect drug exposure.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly (e.g., weekly after initiation/dose change, then monthly or every 3-6 months once stable)

Target: <130/80 mmHg (individualized based on guidelines and patient comorbidities)

Action Threshold: If BP remains uncontrolled or drops excessively, adjust dose or consider alternative therapy.

Serum Creatinine and eGFR

Frequency: Periodically (e.g., 1-2 weeks after initiation/dose change, then every 6-12 months, or more frequently in patients with renal impairment or on concomitant medications affecting renal function)

Target: Stable or within acceptable limits for patient's baseline

Action Threshold: Significant increase in creatinine or decrease in eGFR (e.g., >30% from baseline) may warrant dose reduction or discontinuation.

Serum Potassium

Frequency: Periodically (e.g., 1-2 weeks after initiation/dose change, then every 6-12 months, or more frequently in patients at risk for hyperkalemia)

Target: 3.5-5.0 mEq/L

Action Threshold: Potassium >5.5 mEq/L may require intervention (e.g., dose reduction, discontinuation, or management of hyperkalemia).

đŸ‘ī¸

Symptom Monitoring

  • Dizziness
  • Lightheadedness
  • Fatigue
  • Peripheral edema (swelling of ankles/feet)
  • Headache
  • Flushing
  • Palpitations
  • Shortness of breath
  • Unusual weight gain
  • Signs of angioedema (swelling of face, lips, tongue, throat, difficulty breathing/swallowing)

Special Patient Groups

🤰

Pregnancy

Contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury and death associated with valsartan (an ARB). Discontinue as soon as pregnancy is detected. First trimester exposure data is limited but potential risks cannot be excluded.

Trimester-Specific Risks:

First Trimester: Limited human data. Animal studies show risk. Potential for fetal harm cannot be ruled out.
Second Trimester: High risk of fetal injury (e.g., oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, renal failure) and death.
Third Trimester: High risk of fetal injury (e.g., oligohydramnios, fetal lung hypoplasia, skeletal deformations, anuria, renal failure) and death.
🤱

Lactation

Amlodipine is present in human milk. It is unknown if valsartan is present in human milk. Due to the potential for serious adverse reactions in breastfed infants, including hypotension and hyperkalemia, breastfeeding is not recommended during treatment with Exforge.

Infant Risk: Potential for hypotension, hyperkalemia, and other adverse effects. Risk is low for amlodipine but unknown for valsartan.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established in pediatric patients (under 18 years of age). Not recommended for use in this population.

👴

Geriatric Use

No overall differences in efficacy or safety were observed between elderly (65 years and older) and younger patients. However, greater sensitivity of some older individuals cannot be ruled out. Start at the lower end of the dosing range and monitor renal function and potassium closely, especially in those with impaired renal function.

Clinical Information

💎

Clinical Pearls

  • Exforge is a fixed-dose combination and should not be used as initial therapy for hypertension unless the patient's blood pressure is adequately controlled on the individual components or if the patient requires the specific combination for optimal blood pressure control.
  • Monitor for peripheral edema, a common side effect of amlodipine, which may be less pronounced with the combination due to valsartan's vasodilatory effects.
  • Counsel patients on the importance of avoiding potassium supplements and salt substitutes containing potassium due to the risk of hyperkalemia with valsartan.
  • Emphasize the critical importance of discontinuing the medication immediately if pregnancy is detected due to the black box warning for fetal toxicity.
  • Patients with severe aortic stenosis may be at increased risk of hypotension with amlodipine due to its vasodilatory effects.
🔄

Alternative Therapies

  • Other Angiotensin Receptor Blockers (ARBs) (e.g., losartan, irbesartan, candesartan)
  • Other Calcium Channel Blockers (CCBs) (e.g., nifedipine, felodipine, diltiazem, verapamil)
  • ACE Inhibitors (e.g., lisinopril, enalapril, ramipril)
  • Thiazide Diuretics (e.g., hydrochlorothiazide, chlorthalidone)
  • Beta-blockers (e.g., metoprolol, carvedilol)
  • Direct Renin Inhibitors (e.g., aliskiren - with caution due to interactions)
💰

Cost & Coverage

Average Cost: $150 - $300 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (generic), Tier 3 (brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to ensure you receive the best possible care.